Aurobindo Pharma CB uses rare premium structure

Strong expansion story allows company to fix conversion price on 25% of the deal in 12 months time; investors compensated by high yield and high bond floor.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES